ProKidney
PROK
71 hedge funds and large institutions have $94.3M invested in ProKidney in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 8 reducing their positions, and 9 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 8
173% more call options, than puts
Call options by funds: $665K | Put options by funds: $244K
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
9% more funds holding
Funds holding: 65 → 71 (+6)
4.87% more ownership
Funds ownership: 34.12% → 38.99% (+4.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $98.8M → $94.3M (-$4.45M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$6.81M |
| 2 |
BlackRock
New York
|
+$6.26M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.81M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.53M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
-$1.74M |
| 2 |
Morgan Stanley
New York
|
-$404K |
| 3 |
Millennium Management
New York
|
-$226K |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$138K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$124K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$1.65K | -672 | Closed |
|
|
IA
77
IFP Advisors
Tampa,
Florida
| – | -$49 | -20 | Closed |
|
78
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$5 | -2 | Closed |
|
|
HWM
79
Hemington Wealth Management
Falls Church,
Virginia
| – | +$225 | +99 | New |
|
PROK Hedge Fund Activity: Q3 2024 in Review
71 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q3 2024, worth a combined $94.3M — down 4.5% from $98.8M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new PROK positions and 9 closed out — a net gain of 7 holders — while 36 added to existing stakes and 8 trimmed.
The largest buyer was Suvretta Capital Management, adding an estimated $6.81M. The largest seller was Bleichroeder LP, cutting an estimated $1.74M.
- 71 institutional investors held ProKidney (PROK) as of Q3 2024, up from 65 in Q2 2024.
- Funds reported $94.3M of ProKidney stock for Q3 2024, down 4.5% quarter-over-quarter.
- 16 funds opened new ProKidney positions in Q3 2024 and 9 closed out, a net change of +7 holders.
- The largest ProKidney buyer in Q3 2024 was Suvretta Capital Management, an estimated $6.81M added.
- The largest ProKidney seller in Q3 2024 was Bleichroeder LP, an estimated $1.74M sold.
Based on aggregated 13F filings for Q3 2024.